“Routinely providing hepatitis C screening to pregnant women who are undergoing treatment for opioid use disorder can help steer them to effective treatments to eradicate the infection, University of New Mexico researchers have found.
In a new study published in the journal Maternal and Child Health (and highlighted in the director’s report of the National Institute on Drug Abuse), the researchers found that a high percentage of women with opioid addictions enrolled in UNM’s Milagro Program, which provides prenatal care for women with substance abuse disorders, tested positive for hepatitis C virus (HCV).
The virus is transmitted in blood, typically through intravenous drug use. It causes damage slowly and with few outward symptoms over a period of decades, but over the long term the infection can result in liver cancer.
Read more at: http://hscnews.unm.edu/news/cascade-of-care
Source: HSCNews.edu – February 26, 2018